COPCOV trial

Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting

 

News:

 

Welcome to the COPCOV team in the Dudley Group

Today Dudley Group Hospital Trust opened recruitment to COPCOV joining Brighton and Sussex Hospitals, Oxford University Hospitals, University Hospitals of Coventry and Warwickshire, Imperial College Healthcare and Morecambe Bay as the study moves towards national role out.

Welcome to the COPCOV team in Morecambe Bay

Today Morecambe Bay Hospital Trust opened recruitment to COPCOV joining Brighton and Sussex Hospitals, Oxford University Hospitals, University Hospitals of Coventry and Warwickshire and Imperial College Healthcare as the study moves towards national role out.


Hydroxychloroquine doses in COVID-19 prevention trials should be safe, study finds.

Now let’s find out if they’re effective.


These Scientists Are Still Studying The World’s Most Controversial Drug,

but They Can’t Find Enough People To Take It


COPCOV study recruits 100 health care workers in the UK


COPCOV Global Study Team Newsletter

Volume 1, Issue 1


Welcome to the COPCOV team in Coventry

Today University Hospitals of Coventry and Warwickshire opened recruitment to COPCOV joining Brighton and Sussex Hospitals, Oxford University Hospitals and Imperial College Healthcare as the study moves towards national role out.


COPCOV study has continued importance

COPCOV investigators Prof Martin Llewelyn and Dr Will Schilling set out the continued importance of the Trial following the publication of negative trials assessing hydroxychloroquine for treatment of COVID-19: Pharmaceutical journal article.


BBC News

Hydroxychloroquine being 'discarded prematurely', say scientists


COPCOV on Sky news

Coronavirus: Oxford study says hydroxychloroquine can not be 'ruled out' as preventative measure, article


COPCOV study recruitment has resumed

This weekend the UK Medicines Healthcare Regulatory Agency has approved further enrolment into the COPCOV trial. We are beginning recruitment again this week and will be working hard to open sites across the UK during July.


Pause in recruitment

We received notice from the UK's MHRA (Medicines and Healthcare Products Regulatory Agency) to pause for now new enrolment into our COPCOV study. We responded promptly to the MHRA, addressing their concerns in detail and await their decision. For now, COPCOV study enrolment is paused around the globe. The safety of our participants is our first priority, as is preventing illness in front-line healthcare workers.


First UK COPCOV site news

First UK site confirms Capacity and Capability at Brighton and Sussex University Hospitals NHS Trust


UK approval given for COPCOV study

Approval given by the Health Research Authority and Care Research Wales for COPCOV to go ahead in England and Wales


First COPCOV participant enrolled

First participants enrolled into the COPCOV trial in Thailand. Further details here


COPCOV in the news

Article in Science Magazine highlights COPCOV to evaluate role of pre-exposure prophylaxis in protecting healthcare workers from COVID-19